Please login to the form below

Not currently logged in
Email:
Password:

IGAS

This page shows the latest IGAS news and features for those working in and with pharma, biotech and healthcare.

Novartis’ iptacopan scores positive results in rare blood disorder PNH

Novartis’ iptacopan scores positive results in rare blood disorder PNH

involvement. This includes IgA nephropathy (IgAN), atypical haemolytic uremic syndrome (aHUS), and membranous nephropathy (MN). ... The European Medicines Agency (EMA) has also granted iptacopan a PRIME designation in C3G, as well as an orphan drug

Latest news

More from news
Approximately 1 fully matching, plus 16 partially matching documents found.

Latest appointments

  • New hires at Nanoform, Leo Pharma and Calliditas New hires at Nanoform, Leo Pharma and Calliditas

    IgA nephropathy (IgAN) – also known as Berger’s disease. ... Currently, there are no approved treatments for IgA Nephropathy, and Nefecon has the potential to be a disease-modifying treatment for patients suffering from this chronic autoimmune disease

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
foxandcat.online

some pressure is helpful but too much of the wrong sort quickly takes its toll. we help creatove agenices manage...

Latest intelligence

Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...
Six ways to improve diversity in clinical trials
Diversity is becoming increasingly important as a focus of clinical trials. This whitepaper gives six approaches that could be implemented to help make diversity a bigger focus on your clinical...